Clostridium perfringens

Kemin Industries Celebrates 20 Years of CLOSTAT™ and Probiotic Excellence in Intestinal Health for Production Animals

Retrieved on: 
Wednesday, April 17, 2024
Kemin Industries, Poultry, Clostridium perfringens, Escherichia coli, Conference, Friends, Salmonella, Livestock, Bacillus, Enterobacteriaceae, Quality of life, Growth

MANILA, Philippines, April 16, 2024 /PRNewswire/ -- Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, is celebrating two decades of CLOSTAT™, its flagship probiotic product for managing intestinal health in poultry and livestock. To commemorate the milestone, the Kemin Animal Nutrition and Health – Asia Pacific business unit hosted an anniversary dinner on Tuesday, April 16, in Manila, Philippines. The event coincided with the 8th International Conference on Poultry Intestinal Health (ICPIH), also held in the country's capital city, on April 17–19.

Key Points: 
  • The event coincided with the 8th International Conference on Poultry Intestinal Health (ICPIH), also held in the country's capital city, on April 17–19.
  • Kemin's probiotic solution has pioneered the promotion of healthy microbiome to drive intestinal resilience, manage gut health challenges, and improve animal productivity.
  • "We are extremely proud of the impact of CLOSTAT over the past 20 years," said Dr. Chris Nelson, President and CEO, Kemin Industries.
  • Click here to see where CLOSTAT and ENTEROSURE are available in the Asia-Pacific region and to learn more about their intestinal health benefits.

Ancera Unveils New Cutting-Edge Detection Tools to Support Productivity, Food Safety, and Interventional Efficacy in Poultry Industry

Retrieved on: 
Tuesday, January 16, 2024
Bird, Food safety, Supply, Weight gain, Total, Health, Command center, Wayfair, Sanitation, Food security, Poultry, Data science, Risk, Software, Quality control, Feces, National library, Clostridium perfringens, TVB, CSM, Microbiology, Poultry farming

BRANFORD, Conn., Jan. 16, 2024 /PRNewswire/ -- Today, Ancera, the innovator of supply chain intelligence, has announced the release of two new microbial detection tools designed to identify and enumerate Clostridium perfringens and Total Viable Bacteria (TVB) in poultry. Ancera's new cutting-edge assays will address critical challenges within the poultry industry, spanning both live operations and processing, in order to help companies increase productivity, food safety, and interventional efficacy.

Key Points: 
  • Ancera's new cutting-edge assays will address critical challenges within the poultry industry, spanning both live operations and processing, in order to help companies increase productivity, food safety, and interventional efficacy.
  • The Clostridium and TVB assays will double the number of novel assays on the PIPER platform," said Arjun Ganesan, CEO of Ancera.
  • "Retail customers see Clostridium perfringens as a productivity and animal welfare concern and our technology can help innovative poultry companies take action and gain market share.
  • According to The National Library of Medicine , Clostridium contributes to a $6 billion revenue loss for the global poultry industry.

ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens

Retrieved on: 
Monday, October 30, 2023
Other Natural Resources, Health, Natural Resources, Pharmaceutical, Biotechnology, Veterinary, Food safety, Escherichia coli, Incidence, Bird, Human, Poultry, Diarrhea, Weight loss, Mortality, Digestion, Prevalence, Salmonella, Coccidiosis, Clostridium perfringens, Campylobacter, Chicken, Disease, Partnership, Drug resistance, Fungal infection, Poultry farming

This new study will be performed under the same conditions as the previous 28-day coccidiosis challenge study, but will be carried out for the full 42-day grow out period typical in the broiler production industry.

Key Points: 
  • This new study will be performed under the same conditions as the previous 28-day coccidiosis challenge study, but will be carried out for the full 42-day grow out period typical in the broiler production industry.
  • “Our coccidiosis product candidate holds potential to transform poultry health management.
  • Products for treating coccidiosis are mostly antibiotic- or ionophore-based, and no significant new commercial technology has been introduced in the past 60 years.
  • Coccidiosis is a common disease for chickens, especially among young chicks, and can be fatal or result in compromised digestion.

IFF Celebrates Achievements of Leading Scientists Across Multiple Fields

Retrieved on: 
Tuesday, October 24, 2023
Knowledge, Science, Gene editing, National Inventors Hall of Fame, Escherichia coli, NYSE, Health, Food, Biotechnology, CRISPR, TM, Invention, Salmonella, Livestock, Research, Creativity, Clostridium perfringens, All rights reserved, SM, Enterococcus, Bacteria, University of California, San Diego, University, Île-de-France Clusters, NIHF, Infection, Pharmaceutical industry, Danisco, Ghent University

NEW YORK, Oct. 24, 2023 /PRNewswire/ -- IFF (NYSE: IFF)—an industry leader in food, beverage, health, biosciences and scent—this week will celebrate groundbreaking achievements in science excellence. Dr. Filip Van Immerseel and Dr. Jack A. Gilbert will receive the IFF Science and Microbiome Science Awards, for their research advancements in the fields of animal nutrition & health and microbiome.[1] Additionally, IFF scientist Dr. Philippe Horvath is being inducted into the National Inventors Hall of Fame® (NIHF) on Oct. 26 for his seminal research on CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) that helped revolutionize the gene editing field.

Key Points: 
  • "At IFF, we believe honoring scientific excellence from our scientists and academics is a great tribute to our heritage of innovation," said Dr. Casper Vroemen, executive vice president, chief R&D and sustainability officer, IFF.
  • "On behalf of the IFF scientific community, I'm proud to celebrate three renowned scientists who are pushing the limits of science to create a better world."
  • IFF Science Award: Filip Van Immerseel of Ghent University, Belgium, was selected for his groundbreaking work in animal nutrition & health.
  • IFF, the IFF Logo, and all trademarks and service marks denoted with TM, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted.

ZIVO Bioscience CEO Issues Letter to Shareholders

Retrieved on: 
Friday, September 23, 2022
Health, Infectious Diseases, Agriculture, Natural Resources, Pharmaceutical, Biotechnology, Veterinary, Securities Exchange Act of 1934, Adoption, Health, Gaps, Incidence, Human, Review, Salmonella, CVB, Poultry, Energy Independence and Security Act of 2007, Chicken, Licensure, Farmer, Acquisition, Growth, Intellectual property, USDA, Immunity, Industry, Clostridium perfringens, Achievement, Securities Act of 1933, Use of Free and Open-Source Software (FOSS) in the U.S. Department of Defense, U.S. Securities and Exchange Commission, Letter, Escherichia coli, Nutrient, CEO, Technology, Vaccine, Goal, Coccidiosis, Board of directors, Leadership, Ill, Agtech, List of life sciences, Veterinary biologic, NASDAQ, Biomass, Board, Research, Security (finance), U.S. Department of Agriculture Cotton Annex, Animal, Immune system, Self-affirmation, Disease, Livestock, Management, Fine chemical, Aquaculture, Campylobacter, Eimeria

Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today issued the following letter to shareholders from its Chairman, President and Chief Executive Officer, John Payne.

Key Points: 
  • Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today issued the following letter to shareholders from its Chairman, President and Chief Executive Officer, John Payne.
  • Through establishing partnerships and scaling our manufacturing capacity, ZIVO is undergoing a transformation aimed at maximizing the value of our product portfolio for our customers, partners, and shareholders.
  • Through this letter Id like to provide an overview of why others find our product candidates to be so attractive.
  • On behalf of the ZIVO team, as well as our Board of Directors, I want to thank our shareholders for their continued support.

Global Processed Meat Market Report (2022 to 2031) - Featuring Cargill, Tyson Foods and Foster Farms Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 7, 2022
Restaurant, Bar, Food, Beverage, Other Retail, Retail, Supermarket, Benchmark, Risk, Organization, Nuggets, Growth, ITC Limited, Coronavirus, ITC, Meat, Plant, Food, Smoking, Taste, Sodium nitrite, Create, Poultry, Clostridium perfringens, Marketing, Food preservation, Chilled

The processed meat market consists of sales of processed meat by entities (organizations, sole traders, and partnerships) that are preserved by curing, smoking, drying, salting, or canning.

Key Points: 
  • The processed meat market consists of sales of processed meat by entities (organizations, sole traders, and partnerships) that are preserved by curing, smoking, drying, salting, or canning.
  • The different processing's include fresh processed meat, raw cooked meat, precooked meat, raw fermented sausages, cured meat, dried meat, others and involves various meat types such as poultry, beef, mutton, pork, others.
  • The increasing consumption of various processed food products is expected to propel the growth of the processed meat market going forward.
  • The countries covered in the processed meat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Amlan to Feature New Product, Phylox® and Share Recent Commercial Varium® Research at XLVI ANECA 2022 Annual Congress

Retrieved on: 
Tuesday, March 15, 2022
Program, Solution, Clostridium perfringens, UNAM, GLOBE, Ionophore, Health, ODC, National Association, XLVI, Government, Clostridial necrotizing enteritis, Transport, ANECA, Economics, Poultry, Marketing, Research, Congress, Bird, NYSE, Industry, Poultry Science Association, Salmonella, Culture, New, VP, Feed manufacturing, Coccidiosis, Eimeria

The active ingredients in Phylox have been demonstrated through independent research to interrupt the life cycle of various Eimeria species, the causative agents in coccidiosis.

Key Points: 
  • The active ingredients in Phylox have been demonstrated through independent research to interrupt the life cycle of various Eimeria species, the causative agents in coccidiosis.
  • The synergistic blend of bioactive phytochemicals in Phylox also helps strengthen bird intestinal integrity and supports strong, natural immune function.
  • Amlan is taking part in multiple events throughout the ANECA congress including hosting a presentation at 9 a.m. on Thursday, March 31, byDr.
  • Further details about the XLVI ANECA 2022 Annual Congress can be found here .

Kemin Launches VANNIX™ C4 for Poultry Producers in the United States

Retrieved on: 
Thursday, January 16, 2020
Livestock, Phytogenics, Clostridium perfringens, Eimeria, Feed additive, Additive, Organisms, Primary industries, Industries, Delacon

VANNIX C4 is a proprietary formulation of natural, gut-health-fortifying ingredients designed as a cost-effective solution for producers to minimize the impact of enteric challenges on poultry performance.

Key Points: 
  • VANNIX C4 is a proprietary formulation of natural, gut-health-fortifying ingredients designed as a cost-effective solution for producers to minimize the impact of enteric challenges on poultry performance.
  • Independently published research has shown that select phytogenic molecules can reduce the impact of enteritic pathogens such as Eimeria and Clostridium perfringens on poultry performance.
  • "As a novel phytogenic feed additive, VANNIX C4 offers producers a new tool to support and rotate into gut health management programs, helping to promote performance and preserve the efficacy of current products."
  • VANNIX C4 differs from conventional phytogenic feed additives on the market today:
    VANNIX C4 joins the existing line of "Knock Out" solutions in the Kemin Gut Health Triple Check : CLOSTAT, CLOSTAT WS and KEM SAN.

Peak Summer: More than One in Six People Likely to Get Food Poisoning

Retrieved on: 
Wednesday, August 26, 2020
Food safety, Foodborne illness, Health, Medicine, Nausea, Articles, RTT, Danger Zone, Clostridium perfringens, Food safety, Vomiting, Foodborne illness, Articles, Health, Nausea, RTT, Medicine, Danger Zone

CHICAGO, July 2, 2019 /PRNewswire/ --Like sunburn and bug bites, food poisoning is a common warm-weather malady that can cause painful consequences.

Key Points: 
  • CHICAGO, July 2, 2019 /PRNewswire/ --Like sunburn and bug bites, food poisoning is a common warm-weather malady that can cause painful consequences.
  • Food poisoning symptoms, which may start anywhere from within hours to 10 days of eating contaminated food, most often include an upset stomach, stomach cramps, nausea, vomiting, diarrhea and/or fever.
  • Consulting a food thermometer will ensure foods reach appropriate internal temperatures high enough to kill bacteria.
  • Refrigerate leftovers within 2 hours of cooking or within 1 hour if the food was served in temperatures reaching 90F.

Trans-Atlantic study finds promising results with Visbiome Vet, a high potency probiotic, in dogs with severe form of acute diarrhea

Retrieved on: 
Wednesday, December 12, 2018
Bacteria, Digestive system, Bacteriology, Probiotics, Lactobacillaceae, Gram-positive bacteria, Clostridium perfringens, Antibiotic-associated diarrhea, Lactobacillus casei

The study evaluated the impact of Visbiome Vet probiotic consumption on dogs with acute hemorrhagic diarrhea syndrome (AHDS).

Key Points: 
  • The study evaluated the impact of Visbiome Vet probiotic consumption on dogs with acute hemorrhagic diarrhea syndrome (AHDS).
  • The placebo-controlled, blinded trial found that dogs administered the probiotic experienced significantly faster clinical recovery over the 21 days of the trial.
  • Dogs in the treatment group also demonstrated higher concentrations of healthy microbes and significantly lower quantities of the pathogenic bacterium Clostridium perfringens.
  • Visbiome Vet is a high potency, eight-strain, probiotic, which has been the subject of numerous recent clinical publications in companion animals.